Oregon's COVID-19 vaccine breakthrough report of March 17, 2022

Oregon Health Authority (OHA)’s most recent update on COVID-19 breakthrough cases, released Thursday, March 17th 2022, reported 2,532 cases of COVID-19 during the week of March 6 to March 12.


Of those cases, 2,370, or 93.6%, were unvaccinated people and 945, or 37.3%, were vaccine breakthrough cases. Among the breakthrough cases, 468, or 49.5%, were fully vaccinated and boosted.

The median age of the breakthrough cases during that period was 51. Seven breakthrough cases involved residents of care facilities, senior living communities or other congregate care settings. There were 43 cases in people ages 12 to 17.

To date, there have been 195,600 COVID-19 vaccine breakthrough cases in Oregon. Of those cases, 45,386, or 23.2%, were fully vaccinated. The median age of all cases is 41. (it changed to 46 in April)

To date, 2.5% of all vaccine breakthrough cases have been hospitalized and 0.6% have died. The median age of vaccinated people who died is 80.

578 breakthrough fatalities were among those whose with primary COVID-19 immunization series done with Pfizer vaccine (6,973.3 cases per every 100,000 vaccinated), 351 with Moderna (6,245.9 cases per every 100,000 vaccinated) and 157 with Johnson and Johnson (7,811.9 cases per every 100,000 vaccinated). 


READ MORE

REFERENCE

COVID-19 Breakthrough Report. Oregon’s Weekly Surveillance Summary by Oregon Health Authority. March 17, 2022

Comments

Post a Comment

Popular posts from this blog

A New Onset of Ulcerative Colitis post-2nd-breakthrough-COVID-19

Image
A 21-year-old non-smoking Caucasian male with a history of acute pancreatitis but no other medical issues or family history had two doses of the BNT162b2 mRNA COVID-19 vaccine.  Four months after the second dose he had his first episode of COVID-19. Although not hypoxic, he felt pretty unwell for a week, with a severe cough, fever, generalized body ache, headache, and loss of taste. He received the third dose of the vaccine two months after recovering from COVID. Nine months after the third dose, he had the second episode of COVID-19, during which he was mildly unwell for three days, recovered, and did not require any anti-viral medication or antibiotics. One week post the second episode of COVID-19, he developed diarrhea and abdominal pain. It then progressed to bloody diarrhea. Ulcerative colitis was diagnosed based on his clinical symptoms, biopsy changes, and the exclusion of other causes.  There are ten published case reports about the newly diagnosed ulcerative colitis ...
Read more

COVID in May

Image
Concerns about a potential resurgence of COVID-19 are mounting as summer 2024 approaches.  This is driven by several indicators, including social media posts, healthcare data, and wastewater surveillance across different regions. Our study findings corroborate this trend.  While many forecasters anticipate a surge, others expect a gradual increase through the end of May, and then a decline again around early June. Reports from social media suggest emerging clusters of COVID-19 in Texas, several Canadian provinces, the UK, and on cruises in northern regions such as a Norwegian cruise to Alaska.  Data from Alberta's Respiratory virus dashboard   (total weekly laboratory-confirmed COVID-19 cases) and wastewater surveillance in Calgary indicate an uptick in COVID-19 cases starting April 2024. The most recent statistics from Alberta Health reveal a significant increase in hospitalizations due to COVID-19, with 114 individuals currently hospitalized—an incr...
Read more

Chronic SARS-CoV-2 Shedding

Image
Chronic viral shedding, a condition where the virus continues to be released from an individual's body long after the initial infection, has been observed in many infectious diseases, including COVID-19.  In such cases, individuals may remain asymptomatic or experience only mild symptoms while the virus persists. It remains detectable in repeated tests over an extended period and can still infect others even in nasal swab is negative (which happens quite often ). This was evident in our study.    Recent research by Conway et al. (2024) highlights the possibility of chronic SARS-CoV-2 infection, extending over several months and potentially years. Other studies have documented prolonged asymptomatic infections and extended viral shedding in moderate to severe beyond hospital discharge. Analysis of sequencing data on UK samples taken between 2 November 2020 and 15 August 2022 lead to estimates that 0.1–0.5% of infections may become persistent with typically rebounding high ...
Read more